G. Bradley Cole

2018

In 2018, G. Bradley Cole earned a total compensation of $1.9M as Chief Financial Officer at Genomic Health, a 20% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$397,720
Option Awards$740,077
Salary$543,700
Stock Awards$252,064
Total$1,933,561

Cole received $740.1K in option awards, accounting for 38% of the total pay in 2018.

Cole also received $397.7K in non-equity incentive plan, $543.7K in salary and $252.1K in stock awards.

Rankings

In 2018, G. Bradley Cole's compensation ranked 5,927th out of 14,244 executives tracked by ExecPay. In other words, Cole earned more than 58.4% of executives.

ClassificationRankingPercentile
All
5,927
out of 14,244
58th
Division
Services
1,161
out of 2,374
51st
Major group
Health Services
90
out of 218
59th
Industry group
Medical And Dental Laboratories
19
out of 76
75th
Industry
Medical Laboratories
19
out of 76
75th
Source: SEC filing on April 25, 2019.

Cole's colleagues

We found four more compensation records of executives who worked with G. Bradley Cole at Genomic Health in 2018.

2018

Kimberly Popovits

Genomic Health

Chief Executive Officer

2018

Frederic Pla

Genomic Health

Chief Operating Officer

2018

Steven Shak

Genomic Health

Chief Scientific Officer

2018

James Vaughn

Genomic Health

Chief U.S. Commercial Officer

News

You may also like